McNairy Matthew, Gardetto Nancy, Clopton Paul, Garcia Alex, Krishnaswamy Padma, Kazanegra Radmila, Ziegler Michael, Maisel Alan S
Division of Cardiology and the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, Calif 92161, USA.
Am Heart J. 2002 Mar;143(3):406-11. doi: 10.1067/mhj.2002.120148.
B-natriuretic peptide (BNP), a neurohormone secreted from the cardiac ventricles, reflects left ventricular pressure and correlates to disease severity and prognosis. The fact that BNP levels can now be measured by a rapid assay suggests its potential usefulness in the outpatient clinic. However, if patient activity were to markedly alter BNP levels, its use would be less attractive for monitoring patients in the outpatient clinical setting.
A total of 30 patients (10 normal, 10 New York Heart Association [NYHA] class I-II, 10 NYHA class III-IV) exercised with an upright bicycle protocol. Exercise was carried out to 75% of maximum heart rate, and venous blood was sampled before, immediately after, and 1 hour after completion of exercise. Plasma levels of BNP, epinephrine, and norepinephrine were measured.
BNP levels at baseline were 29 +/- 11 pg/mL for normal subjects, 126 +/- 26 pg/mL for NYHA I-II subjects, and 1712 +/- 356 pg/mL for NYHA III-IV subjects. The change in BNP levels with exercise was significantly lower than the change in epinephrine and norepinephrine (P <.001). In normal subjects, BNP increased from 29 pg/mL to 44 pg/mL with peak exercise, still within the range of normal (<100 pg/mL). This is compared with larger increases of norepinephrine (716 pg/mL to 1278 pg/mL) and epinephrine (52 pg/mL to 86 pg/mL) with exercise in normal subjects. There were also only small increases in BNP with exercise in patients with congestive heart failure (NYHA I-II, 30%; NYHA III-IV, 18%). For the same groups, epinephrine levels increased by 218% and 312%, respectively, and norepinephrine levels increased by 232% and 163%, respectively. One hour after completion of exercise, there were only minimal changes in BNP levels from baseline state in normal subjects (+0.9%) and patients with NYHA I-II (3.8%). In patients with NYHA III-IV, there was a 15% increase from baseline 1 hour after exercise.
BNP levels show only minor changes with vigorous exercise, making it unlikely that a normal patient would be classified as having congestive heart failure based on a BNP level obtained after activity. Prior activity should not influence BNP levels in patients with congestive heart failure. Therefore, when a patient presents to clinic with a marked change in their BNP level, it may reflect a real change in their condition.
B型利钠肽(BNP)是一种由心室分泌的神经激素,反映左心室压力,并与疾病严重程度和预后相关。目前可通过快速检测法测定BNP水平,这表明其在门诊可能具有潜在用途。然而,如果患者活动会显著改变BNP水平,那么在门诊临床环境中用于监测患者的吸引力就会降低。
共有30例患者(10例正常,10例纽约心脏协会[NYHA]I-II级,10例NYHA III-IV级)按照直立自行车运动方案进行运动。运动至最大心率的75%,在运动前、运动结束后即刻及运动结束后1小时采集静脉血样。检测血浆BNP、肾上腺素和去甲肾上腺素水平。
正常受试者基线时BNP水平为29±11 pg/mL,NYHA I-II级受试者为126±26 pg/mL,NYHA III-IV级受试者为1712±356 pg/mL。运动时BNP水平的变化显著低于肾上腺素和去甲肾上腺素的变化(P<.001)。在正常受试者中,运动高峰时BNP从29 pg/mL升至44 pg/mL,仍在正常范围内(<100 pg/mL)。相比之下,正常受试者运动时去甲肾上腺素(从716 pg/mL升至1278 pg/mL)和肾上腺素(从52 pg/mL升至86 pg/mL)的升高幅度更大。充血性心力衰竭患者(NYHA I-II级,30%;NYHA III-IV级,18%)运动时BNP也仅有小幅升高。对于同一组患者,肾上腺素水平分别升高218%和312%,去甲肾上腺素水平分别升高232%和163%。运动结束1小时后,正常受试者和NYHA I-II级患者的BNP水平与基线状态相比仅有微小变化(分别为+0.9%和3.8%)。NYHA III-IV级患者运动后1小时,BNP水平较基线升高15%。
剧烈运动时BNP水平仅出现微小变化,因此正常患者不太可能因运动后测得的BNP水平而被误诊为充血性心力衰竭。既往活动不应影响充血性心力衰竭患者的BNP水平。因此,当患者就诊时BNP水平出现显著变化,可能反映其病情的实际变化。